Menu
Back to User profile » Dr Yin-Ching Chuang
Papers published by Dr Yin-Ching Chuang:
Antimicrobial Susceptibility of E. coli Isolates from Intra-Abdominal Infections in the Asia-Pacific Region: Trends in Ciprofloxacin, Ceftriaxone, Cefepime, and Piperacillin/Tazobactam Susceptibility
Tsai CH, Chen YC, Chen PY, Lai CC, Tang HJ, Chuang YC, Chen CC, Ho CH, Hsu WY, Chang TH
Infection and Drug Resistance 2023, 16:5599-5611
Published Date: 25 August 2023
Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015
Chang YT, Siu LK, Wang JT, Wu TL, Chen YH, Chuang YC, Lin JC, Lu PL
Infection and Drug Resistance 2019, 12:2113-2123
Published Date: 16 July 2019
In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
Lai CC, Chen CC, Lu YC, Chuang YC, Tang HJ
Infection and Drug Resistance 2019, 12:25-29
Published Date: 20 December 2018
Simultaneous three Enterobacteriaceae with different bla NDM-1-encoding plasmids in a patient transferred from mainland China to Taiwan
Lai CC, Chen CC, Lu YC, Chen HJ, Su BA, Weng TC, Chiu YH, Toh HS, Zhang CC, Chiang SR, Chuang YC, Tang HJ
Infection and Drug Resistance 2018, 11:2555-2560
Published Date: 7 December 2018
Appropriate composites of cefoperazone–sulbactam against multidrug-resistant organisms
Lai CC, Chen CC, Lu YC, Lin TP, Chuang YC, Tang HJ
Infection and Drug Resistance 2018, 11:1441-1445
Published Date: 11 September 2018
The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA
Lai CC, Chen CC, Lu YC, Chuang YC, Tang HJ
Infection and Drug Resistance 2018, 11:681-687
Published Date: 3 May 2018